{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-community-engagement-requirements-in-lmic-contexts”
},
“headline”: “SOP for Community Engagement Requirements in LMIC Contexts”,
“description”: “This SOP outlines standardized procedures for community engagement in clinical trials conducted in low- and middle-income countries (LMICs). It ensures compliance with WHO expectations, ethical standards, and cultural sensitivity while fostering trust and transparency with trial communities.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Community Engagement Requirements in LMIC Contexts

Purpose

The purpose of this SOP is to define structured community engagement practices for clinical trials conducted in low- and middle-income countries (LMICs). Community engagement ensures ethical trial conduct, cultural sensitivity, trust-building, and alignment with WHO expectations for equitable participation and transparency in clinical research.

Scope

This SOP applies to sponsors, CROs, investigators, community advisory boards (CABs), and ethics committees involved in trials in LMICs. It covers strategies for communication, cultural adaptation, engagement activities, and documentation of community interactions.

Responsibilities

• Sponsor: Ensures trial design includes adequate provisions for community engagement.
• CRO: Coordinates and documents engagement activities at site and community level.
• Investigator: Engages local communities, addresses concerns, and maintains records.
• Community Advisory Boards (CAB): Provides feedback and supports trial acceptability in the local context.
• EC: Reviews engagement strategies as part of ethical approval process.

Accountability

The Principal Investigator (PI) is accountable for ensuring community engagement activities are culturally appropriate, documented, and aligned with WHO ethical guidelines.

Procedure

1. Community Mapping
1.1 Identify relevant community stakeholders (leaders, health workers, NGOs).
1.2 Conduct baseline cultural and literacy assessment.
1.3 Record in Community Mapping Log (Annexure-1).

2. Engagement Planning
2.1 Develop a Community Engagement Plan (CEP) tailored to local context.
2.2 Translate key trial information into local languages.
2.3 Document plan in Engagement Planning Log (Annexure-2).

3. Engagement Activities
3.1 Conduct informational meetings, workshops, and Q&A sessions.
3.2 Establish community advisory boards.
3.3 Document activities in Engagement Activity Log (Annexure-3).

4. Feedback and Grievance Mechanisms
4.1 Implement community feedback systems (meetings, hotlines).
4.2 Record in Feedback and Grievance Log (Annexure-4).

5. Monitoring and Reporting
5.1 Monitor engagement effectiveness using surveys and attendance records.
5.2 Report engagement outcomes to EC and sponsor.
5.3 Document in Monitoring and Reporting Log (Annexure-5).

Abbreviations

• SOP: Standard Operating Procedure
• LMIC: Low- and Middle-Income Countries
• WHO: World Health Organization
• CRO: Contract Research Organization
• EC: Ethics Committee
• PI: Principal Investigator
• CAB: Community Advisory Board

Documents

1. Community Mapping Log (Annexure-1)
2. Engagement Planning Log (Annexure-2)
3. Engagement Activity Log (Annexure-3)
4. Feedback and Grievance Log (Annexure-4)
5. Monitoring and Reporting Log (Annexure-5)

References

• WHO – Clinical Trials Registry Platform
• WHO – Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants
• ICMR – National Ethical Guidelines

Version: 1.0

Approval Section

Annexures

Annexure-1: Community Mapping Log

Annexure-2: Engagement Planning Log

Annexure-3: Engagement Activity Log

Annexure-4: Feedback and Grievance Log

Annexure-5: Monitoring and Reporting Log

Revision History

For more SOPs visit: Pharma SOP